Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Aircraft parts maker TransDigm set to replace Baxalta on S&P 500

Published 05/27/2016, 07:28 PM
Updated 05/27/2016, 07:31 PM
TransDigm will replace drug manufacturer Baxalta on the S&P 500 at the close of trading next Thursday

Investing.com -- Shares in Transdigm Group Incorporated (NYSE:TDG) soared nearly 4% in after-hours trading, after the S&P Dow Jones Indices announced that the aircraft component manufacturer will join the S&P 500 Composite index on June 2.

TransDigm, a Cleveland-based company which develops, distributes and produces commercial and military aircraft components, will replace Baxalta Inc (NYSE:BXLT) which is being acquired by Ireland pharmaceutical company SHPG at the close of trading on Thursday. Earlier in Friday's session, Baxalta shareholders approved the $32 billion merger between the drug makers. The merger will help create one of the world's leading companies in treating hemophilia.

On Wednesday, TransDigm announced the offering of $950 million of 6.375% senior subordinated notes, due in 2026. The company intends to use the proceeds to help fund a percentage of its acquisition of ILC Holdings, the parent company of Data Device Corporation (DDC). A day earlier, TransDigm announced that it agreed to terms with ILC Holdings to purchase DDC, a leading supplier of databus and power supply products in global aerospace markets for $1 billion in cash. The offering is expected to close on June 9.

During the second quarter of Fiscal Year 2016, TransDigm finished with net sales of $796.8 million for the three-month period ending in early-April, representing a gain of 28.7% on an annual basis. In addition, TransDigm reported earnings of $138.6 million, a spike of 25% from the previous year, as upwardly revised EBITDA surged 28% to $368.6 million.

As a result, the company increased its full-year revenue guidance to a range between $3.151 and $3.181 billion, while raising its annual EPS outlook to a level between 9.89 and 10.13. In 2015, TransDigm earned full-year revenue of $2.707 billion amounting to earnings per share of 7.84.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"We saw signs of improvement in the commercial aftermarket as second quarter sales rose sharply versus the prior year. After a number of quarters of disconnect, these results are encouraging," TransDigm CEO Nicholas Howley said on May 10. "The defense picture was mixed with sales slightly down versus the prior year quarter, but bookings were up significantly.

Shares in TransDigm surged 10.13 or 3.96% to 266.00 in after-hours trading.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.